pei.de Scam Check: 100/100 Trust | ScamMinder

This website appears legitimate based on AI analysis.

https://pei.de redirected to https//www.pei.de during the time we crawled it. The Paul-Ehrlich-Institut (PEI) is a German federal institute that is part of the Federal Ministry of Health. It is responsible for the evaluation and authorization of biomedicines, including vaccines, and for the monitoring of their safety after they have been placed on the market. The PEI also conducts research in the field of biomedicines and is involved in international collaborations and regulatory activities. The website of the Paul-Ehrlich-Institut (PEI) provides information about its various functions and activities. It serves as a platform for communicating the institute's role in ensuring the quality, efficacy, and safety of biomedicines, particularly in the context of public health. Key areas covered on the website include: 1. **Institute Overview**: This section provides an introduction to the PEI, including its history, organizational structure, and its role as a federal institute under the Ministry of Health. 2. **Biomedicines**: Information about different types of biomedicines, such as vaccines, allergens, antibodies, and more, is available. This section likely details the PEI's involvement in the evaluation and regulation of these products. 3. **Safety Monitoring**: Given the critical role of the PEI in monitoring the safety of biomedicines, there are likely resources and information related to pharmacovigilance and adverse event reporting. 4. **Regulatory Activities**: This section may cover the institute's regulatory functions, including the authorization and approval processes for biomedicines, as well as its involvement in international regulatory networks. 5. **Research and Collaboration**: Information about the PEI's research activities, partnerships, and collaborations, especially at the international level, is likely to be featured. 6. **News and Events**: Updates on the latest developments, news, and events related to the institute's work, including conferences, publications, and other relevant activities. 7. **Publications and Resources**: This section may provide access to official publications, reports, guidelines, and other resources related to the PEI's work in the field of biomedicines. 8. **Contact Information**: Details on how to get in touch with the institute, including for specific inquiries, feedback, or media-related matters. Given the nature of the PEI's work, the website is expected to be a reliable and authoritative source of information on the evaluation, regulation, and safety monitoring of biomedicines, particularly in the context of public health in Germany. It is likely to be of interest to healthcare professionals, researchers, regulatory authorities, and the general public seeking information on these topics."

• The Paul-Ehrlich-Institut (PEI) is a German federal institute that is part of the Federal Ministry of Health. It is responsible for the evaluation and authorization of biomedicines, including vaccines, and for the monitoring of their safety after they have been placed on the market. The PEI also conducts research in the field of biomedicines and is involved in international collaborations and regulatory activities. The website of the Paul-Ehrlich-Institut (PEI) provides information about its various functions and activities. It serves as a platform for communicating the institute's role in ensuring the quality, efficacy, and safety of biomedicines, particularly in the context of public health. Key areas covered on the website include: 1. **Institute Overview**: This section provides an introduction to the PEI, including its history, organizational structure, and its role as a federal institute under the Ministry of Health. 2. **Biomedicines**: Information about different types of biomedicines, such as vaccines, allergens, antibodies, and more, is available. This section likely details the PEI's involvement in the evaluation and regulation of these products. 3. **Safety Monitoring**: Given the critical role of the PEI in monitoring the safety of biomedicines, there are likely resources and information related to pharmacovigilance and adverse event reporting. 4. **Regulatory Activities**: This section may cover the institute's regulatory functions, including the authorization and approval processes for biomedicines, as well as its involvement in international regulatory networks. 5. **Research and Collaboration**: Information about the PEI's research activities, partnerships, and collaborations, especially at the international level, is likely to be featured. 6. **News and Events**: Updates on the latest developments, news, and events related to the institute's work, including conferences, publications, and other relevant activities. 7. **Publications and Resources**: This section may provide access to official publications, reports, guidelines, and other resources related to the PEI's work in the field of biomedicines. 8. **Contact Information**: Details on how to get in touch with the institute, including for specific inquiries, feedback, or media-related matters. Given the nature of the PEI's work, the website is expected to be a reliable and authoritative source of information on the evaluation, regulation, and safety monitoring of biomedicines, particularly in the context of public health in Germany. It is likely to be of interest to healthcare professionals, researchers, regulatory authorities, and the general public seeking information on these topics.